Stock Evaluator: Gelteq Limited (GELS)

Gelteq Limited GELS

$0.52 -0.03 -5.61%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 19,548
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Financial Summary

Share Statistics GELS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $5.8 $579.1 4%
Shares Out (Mil) 7.0 43.0 17%
Institutional Ownership 6.2% 84.3% 6%
Float (Mil) 5.2 46.8 12%
Beta na 0.62 na
Avg Daily Volume (000s) 149 285 40%
Price Change
(52-week)
(71.9%) 63.8% 9%
Growth GELS Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 6.7% na
Net Income (5yr) (71.1%) (1.4%) 4%
EPS (5yr) (33.1%) 14.9% 7
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) (26.5%) (14.9%) 23%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials GELS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $0 $272 1%
Net Income (TTM) (Mil) ($5) ($11) 34%
EPS (TTM) ($0.463) ($0.500) 28%
Operating Cash Flow (TTM) (Mil) ($2) ($6) 28%
Net Cash Flow (TTM) (Mil) ($2) $4 38%
Long-Term Debt (Q1) (Mil) $0 $7 0%
Enterprise Value (Q1) (Mil) $10 $522 7%
Valuation GELS Industry
Median
Percentile
(All Stocks)
P/B 0.61 2.73 11%
P/E na 20.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.2 na
Ratios GELS Industry
Median
Percentile
(All Stocks)
Gross Margin 75.5% 65.9% 86%
Net Margin na 0.7% na
ROA (32.6%) (24.6%) 16%
ROE (44.8%) (19.7%) 16%
Liabilities to Assets 29.4% 35.5% 21%
F-Score 2 3 7%

Gelteq Limited did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors